{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:39:30Z","timestamp":1790437170166,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Association Fran\u00e7aise contre les Myopathies AFM-T\u00e9l\u00e9thon"},{"name":"Institute of Myology"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.omtm.2020.03.011","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T07:18:54Z","timestamp":1584429534000},"page":"695-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Combined Treatment with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer-PPMO and AAV-U7 Rescues the Severe DMD Phenotype in Mice"],"prefix":"10.1016","volume":"17","author":[{"given":"Anne","family":"Forand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Muchir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Mougenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sevoz-Couche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Peccate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9gane","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Izabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Lorain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Pi\u00e9tri-Rouxel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.03.011_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2020.03.011_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/338259a0","article-title":"Association of dystrophin and an integral membrane glycoprotein","volume":"338","author":"Campbell","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.03.011_bib3","series-title":"StatPearls","article-title":"Dystrophinopathies","author":"Morales","year":"2018"},{"key":"10.1016\/j.omtm.2020.03.011_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","article-title":"Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review","volume":"73","author":"Gatheridge","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.omtm.2020.03.011_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm9010001","article-title":"Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches","volume":"9","author":"Shimizu-Motohashi","year":"2019","journal-title":"J.\u00a0Pers. Med."},{"key":"10.1016\/j.omtm.2020.03.011_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2020.03.011_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-med-081117-010451","article-title":"CRISPR Correction of Duchenne Muscular Dystrophy","volume":"70","author":"Min","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.omtm.2020.03.011_bib8","doi-asserted-by":"crossref","first-page":"e0228072","DOI":"10.1371\/journal.pone.0228072","article-title":"Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy","volume":"15","author":"Mata L\u00f3pez","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.03.011_bib9","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1126\/science.1104297","article-title":"Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping","volume":"306","author":"Goyenvalle","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.03.011_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/ard.1991.1.141","article-title":"Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3\u2032 exonuclease in plasma","volume":"1","author":"Eder","year":"1991","journal-title":"Antisense Res. Dev."},{"key":"10.1016\/j.omtm.2020.03.011_bib11","first-page":"93","article-title":"Antisense treatments for biothreat agents","volume":"8","author":"Warfield","year":"2006","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/mt.2010.219","article-title":"The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy","volume":"19","author":"Lu","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21627","article-title":"Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs","volume":"65","author":"Yokota","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2020.03.011_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-Penetrating Peptides: From Basic Research to Clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.omtm.2020.03.011_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ebiom.2019.06.036","article-title":"Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases","volume":"45","author":"Tsoumpra","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtm.2020.03.011_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtm.2020.03.011_bib17","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1093\/hmg\/dds082","article-title":"Rescue of severely affected dystrophin\/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping","volume":"21","author":"Goyenvalle","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.03.011_bib18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/mt.2011.264","article-title":"Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping","volume":"20","author":"Bish","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib19","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1038\/mt.2012.181","article-title":"Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping","volume":"20","author":"Vulin","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib20","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/mt.2014.151","article-title":"Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients","volume":"22","author":"Le Guiner","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib21","doi-asserted-by":"crossref","first-page":"16105","DOI":"10.1038\/ncomms16105","article-title":"Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy","volume":"8","author":"Le Guiner","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2020.03.011_bib22","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/hum.2019.143","article-title":"Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome","volume":"30","author":"Aronson","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.mt.6300377","article-title":"Transient immunomodulation allows repeated injections of AAV1 and correction of muscular dystrophy in multiple muscles","volume":"16","author":"Lorain","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/mt.2013.121","article-title":"AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy","volume":"21","author":"Le Hir","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.omtn.2019.08.014","article-title":"Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation","volume":"18","author":"Breuel","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2020.03.011_bib26","doi-asserted-by":"crossref","first-page":"9828725","DOI":"10.1155\/2018\/9828725","article-title":"Cortical AAV-CNTF Gene Therapy Combined with Intraspinal Mesenchymal Precursor Cell Transplantation Promotes Functional and Morphological Outcomes after Spinal Cord Injury in Adult Rats","volume":"2018","author":"Hodgetts","year":"2018","journal-title":"Neural Plast."},{"key":"10.1016\/j.omtm.2020.03.011_bib27","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/hmg\/ddw201","article-title":"Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles","volume":"25","author":"Peccate","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.03.011_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2020.03.011_bib29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/gt.2014.53","article-title":"Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice","volume":"21","author":"Wu","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/mt.2009.248","article-title":"Prevention of dystrophic pathology in severely affected dystrophin\/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping","volume":"18","author":"Goyenvalle","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/mt.2010.261","article-title":"Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice","volume":"19","author":"Malerba","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib32","doi-asserted-by":"crossref","first-page":"8986","DOI":"10.1038\/srep08986","article-title":"Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice","volume":"5","author":"Betts","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2020.03.011_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/hmg\/ddq477","article-title":"Diaphragm rescue alone prevents heart dysfunction in dystrophic mice","volume":"20","author":"Crisp","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.03.011_bib34","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/sj.mt.6300245","article-title":"Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse","volume":"15","author":"Fletcher","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib35","doi-asserted-by":"crossref","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2020.03.011_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13395-015-0041-y","article-title":"Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia","volume":"5","author":"Duddy","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2020.03.011_bib37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2011.06.066","article-title":"Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases","volume":"157","author":"Battistoni","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.omtm.2020.03.011_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/cvr\/cvt228","article-title":"A transgenic mouse model for the simultaneous monitoring of ANF and BNP gene activity during heart development and disease","volume":"101","author":"Sergeeva","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.omtm.2020.03.011_bib39","doi-asserted-by":"crossref","first-page":"H1814","DOI":"10.1152\/ajpheart.2001.280.4.H1814","article-title":"Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles","volume":"280","author":"Reiser","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.omtm.2020.03.011_bib40","doi-asserted-by":"crossref","first-page":"e8335","DOI":"10.1097\/MD.0000000000008335","article-title":"Cardiac conduction disturbances and aging in patients with Duchenne muscular dystrophy","volume":"96","author":"Segawa","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.omtm.2020.03.011_bib41","doi-asserted-by":"crossref","first-page":"13490","DOI":"10.1038\/srep13490","article-title":"Selective Connexin43 Inhibition Prevents Isoproterenol-Induced Arrhythmias and Lethality in Muscular Dystrophy Mice","volume":"5","author":"Gonzalez","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2020.03.011_bib42","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/mt.2011.58","article-title":"Rescue from respiratory dysfunction by transduction of full-length dystrophin to diaphragm via the peritoneal cavity in utrophin\/dystrophin double knockout mice","volume":"19","author":"Ishizaki","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib43","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1089\/hum.2016.041","article-title":"Dystrophin Threshold Level Necessary for Normalization of Neuronal Nitric Oxide Synthase, Inducible Nitric Oxide Synthase, and Ryanodine Receptor-Calcium Release Channel Type 1 Nitrosylation in Golden Retriever Muscular Dystrophy Dystrophinopathy","volume":"27","author":"Gentil","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.03.011_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.29176","article-title":"Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors","volume":"66","author":"H\u00f6sel","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2020.03.011_bib45","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.03.011_bib46","article-title":"Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology","author":"van Westering","year":"2019","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.omtm.2020.03.011_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13395-016-0096-4","article-title":"Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle","volume":"6","author":"Roy","year":"2016","journal-title":"Skelet. Muscle"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:24:51Z","timestamp":1762421091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120300413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":47,"alternative-id":["S2329050120300413"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.03.011","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Treatment with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer-PPMO and AAV-U7 Rescues the Severe DMD Phenotype in Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}